Search
19/12/2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024)
Rodríguez-Jorge, F, Fernández-Velasco, JI, Villarrubia, N, Gracia-Gil, J, Fernández, E, Meca-Lallana, V, Díaz-Pérez, C, de la Maza, SS, Pacheco, EM, Quiroga, A, Ramió-Torrentà, L, Martínez-Yélamos, S, Bau, L, Monreal, E, López-Real, A, Rodero-Romero, A, Borrega, L, Díaz, S, Eguía, P, Espiño, M, Chico-García, JL, Barrero, FJ, Martínez-Ginés, ML, García-Domínguez, JM, de la Fuente, S, Moreno, I, Sainz-Amo, R, Mañé-Martínez, MA, Caminero, A, Castellanos-Pinedo, F, López, AG, Labiano-Fontcuberta, A, Ayuso, L, Abreu, R, Hernández, MA, Meca-Lallana, J, Martín-Aguilar, L, Garcia, AM, Masjuan, J, Costa-Frossard, L, Villar, LM. Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024). Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1535051. PMID:39749346. IF:5.900(Q1/2D).
18/12/2024
Myocardial Injury in Patients with Hip Fracture A HIP ATTACK Randomized Trial Substudy
Borges, FK, Guerra-Farfan, E, Bhandari, M, Patel, A, Slobogean, G, Feibel, RJ, Sancheti, PK, Tiboni, ME, Balaguer-Castro, M, Tandon, V, Tomas-Hernandez, J, Sigamani, A, Sigamani, A, Szczeklik, W, Mcmahon, SJ, Sleczka, P, Ramokgopa, MT, Adinaryanan, S, Umer, M, Jenkinson, RJ, Lawendy, A, Popova, E, Nur, AN, Wang, CY, Vizcaychipi, M, Biccard, BM, Ofori, S, Spence, J, Duceppe, E, Marcucci, M, Harvey, V, Balasubramanian, K, Vincent, J, Tonelli, AC, Devereaux, PJ, HIP ATTACK Investigators. Myocardial Injury in Patients with Hip Fracture A HIP ATTACK Randomized Trial Substudy. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME. 2024; 106(24)DOI:10.2106/JBJS.23.01459. PMID:39052767. IF:4.300(Q1/1D).
17/12/2024
First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
Piedra, A, Martínez-Recio, S, Hernández, A, Morán, T, Arriola, E, Recuero-Borau, J, Cobo, M, Cordeiro, P, Mosquera, J, Fernández, M, García-Campelo, R, Calles, A, Alvarez, R, Zapata-García, M, Isla, D, Callejo, A, Iranzo, P, Serra-López, J, Barba, A, Sullivan, I, Felip, E, Majem, M. First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study. Frontiers in Oncology. 2024; 14DOI:10.3389/fonc.2024.1510278. PMID:39741981. IF:3.300(Q2/4D).
17/12/2024
Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression
Temprano-Sagrera, G, Peypoch, O, Soto, B, Dilmé, J, Juscafresa, LC, Davtian, D, Estadella, MD, Nieto, L, Brown, A, Escudero, JR, Viñuela, A, Camacho, M, Sabater-Lleal, M. Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression. Journal of the American Heart Association. 2024; 13(24)DOI:10.1161/JAHA.124.036082. PMID:39655704. IF:5.300(Q1/2D).
16/12/2024
International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy ( vol 11 , 70 , 2024)
Zeng, GH, Zhong, W, Mazzon, G, Zhu, W, Lahme, S, Khadgi, S, Desai, J, Agrawal, M, Schulsinger, D, Gupta, M, Montanari, E, Martinez, JML, Almousawi, S, Malonzo, VEF, Sriprasad, S, Durutovic, O, Arumuham, V, Ferretti, S, Kamal, W, Xu, KW, Cheng, F, Gao, XF, Cheng, JW, Somani, B, Duvdevani, M, Git, KA, Seitz, C, Bernardo, N, Ibrahim, TAA, Aquino, A, Yasui, T, Fiori, C, Knoll, T, Papatsoris, A, Gadzhiev, N, Zhanbyrbekuly, U, Angerri, O, Ramos, HL, Saltirov, I, Moussa, M, Giusti, G, Vicentini, F, Suarez, EB, Pearle, M, Preminger, GM, Wu, QH, Chai, CA, Ghani, K, Maroccolo, M, Brehmer, M, Osther, PJ, Zawadzki, M, Tursunkulov, A, Kytaibekovich, MN, Abuvohidov, AA, Lara, CAR, Noori, Z, Zanetti, SP, Shrestha, S, de la Rosette, J, Denstedt, J, Ye, ZQ, Sarica, K, Choong, S. International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy ( vol 11 , 70 , 2024). Military Medical Research. 2024; 11(1)DOI:10.1186/s40779-024-00579-8. PMID:39676164. IF:22.900(Q1/1D).
15/12/2024
Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection
Díaz-Pérez, A, Lope-Piedrafita, S, Pérez, B, Vázquez-Sufuentes, P, Rodriguez-Garcia, M, Briones, AM, Navarro, X, Penas, C, Jiménez-Altayó, F. Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection. LIFE SCIENCES. 2024; 359DOI:10.1016/j.lfs.2024.123247. PMID:39547431. IF:5.100(Q1/2D).